Literature DB >> 22926752

A time since onset of injection model for hepatitis C spread amongst injecting drug users.

S Corson1, D Greenhalgh, S J Hutchinson.   

Abstract

Studies of hepatitis C virus (HCV) infection amongst injecting drug users (IDUs) have suggested that this population can be separated into two risk groups (naive and experienced) with different injecting risk behaviours. Understanding the differences between these two groups and how they interact could lead to a better allocation of prevention measures designed to reduce the burden of HCV in this population. In this paper we develop a deterministic, compartmental mathematical model for the spread of HCV in an IDU population that has been separated into two groups (naive and experienced) by time since onset of injection. We will first describe the model. After deriving the system of governing equations, we will examine the basic reproductive number R₀, the existence and uniqueness of equilibrium solutions and the global stability of the disease free equilibrium (DFE) solution. The model behaviour is determined by the basic reproductive number, with R₀ = 1 a critical threshold for endemic HCV prevalence. We will show that when R₀ ≤ 1, and HCV is initially present in the population, the system will tend towards the globally asymptotically stable DFE where HCV has been eliminated from the population. We also show that when R₀ > 1 there exists a unique non-zero equilibrium solution. Then we estimate the value of R₀ from epidemiological data for Glasgow and verify our theoretical results using simulations with realistic parameter values. The numerical results suggest that if R₀ > 1 and the disease is initially present then the system will tend to the unique endemic equilibrium.

Entities:  

Mesh:

Year:  2012        PMID: 22926752     DOI: 10.1007/s00285-012-0577-y

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  29 in total

1.  High risk injecting behaviour among injectors from Glasgow: cross sectional community wide surveys 1990-1999.

Authors:  A Taylor; D Goldberg; S Hutchinson; S Cameron; R Fox
Journal:  J Epidemiol Community Health       Date:  2001-10       Impact factor: 3.710

Review 2.  Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.

Authors:  J M Micallef; J M Kaldor; G J Dore
Journal:  J Viral Hepat       Date:  2006-01       Impact factor: 3.728

3.  Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.

Authors:  A Judd; S Hutchinson; S Wadd; M Hickman; A Taylor; S Jones; J V Parry; S Cameron; T Rhodes; S Ahmed; S Bird; R Fox; A Renton; G V Stimson; D Goldberg
Journal:  J Viral Hepat       Date:  2005-11       Impact factor: 3.728

4.  Building a city wide service for exchanging needles and syringes.

Authors:  L Gruer; J Cameron; L Elliott
Journal:  BMJ       Date:  1993-05-22

5.  Protection against persistence of hepatitis C.

Authors:  Shruti H Mehta; Andrea Cox; Donald R Hoover; Xiao-Hong Wang; Qing Mao; Stuart Ray; Steffanie A Strathdee; David Vlahov; David L Thomas
Journal:  Lancet       Date:  2002-04-27       Impact factor: 79.321

Review 6.  Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: a systematic review.

Authors:  Stephen Corson; David Greenhalgh; Norah Palmateer; Amanda Weir; Sharon Hutchinson
Journal:  Int J Drug Policy       Date:  2010-11-26

7.  Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?

Authors:  A Taylor; D Goldberg; S Hutchinson; S Cameron; S M Gore; J McMenamin; S Green; A Pithie; R Fox
Journal:  J Infect       Date:  2000-03       Impact factor: 6.072

8.  High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.

Authors:  Campbell Kynoch Aitken; Jennifer Lewis; Samantha Lilly Tracy; Timothy Spelman; David Scott Bowden; Mandvi Bharadwaj; Heidi Drummer; Margaret Hellard
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

9.  High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.

Authors:  J M Micallef; V Macdonald; M Jauncey; J Amin; W Rawlinson; I van Beek; J M Kaldor; P A White; G J Dore
Journal:  J Viral Hepat       Date:  2007-06       Impact factor: 3.728

10.  Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience.

Authors:  Elise Roy; Jean-François Boudreau; Jean-François Boivin
Journal:  Drug Alcohol Depend       Date:  2009-02-28       Impact factor: 4.492

View more
  7 in total

1.  The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study.

Authors:  Adam Trickey; Hannah Fraser; Aaron G Lim; Amy Peacock; Samantha Colledge; Josephine G Walker; Janni Leung; Jason Grebely; Sarah Larney; Natasha K Martin; Matthew Hickman; Louisa Degenhardt; Margaret T May; Peter Vickerman
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-04-10

Review 2.  Mathematical modeling of hepatitis c virus (HCV) prevention among people who inject drugs: A review of the literature and insights for elimination strategies.

Authors:  Ashley B Pitcher; Annick Borquez; Britt Skaathun; Natasha K Martin
Journal:  J Theor Biol       Date:  2018-11-16       Impact factor: 2.691

Review 3.  A review of network simulation models of hepatitis C virus and HIV among people who inject drugs.

Authors:  Meghan Bellerose; Lin Zhu; Liesl M Hagan; William W Thompson; Liisa M Randall; Yelena Malyuta; Joshua A Salomon; Benjamin P Linas
Journal:  Int J Drug Policy       Date:  2019-11-15

4.  A Stochastic Differential Equation Model for the Spread of HIV amongst People Who Inject Drugs.

Authors:  Yanfeng Liang; David Greenhalgh; Xuerong Mao
Journal:  Comput Math Methods Med       Date:  2016-03-09       Impact factor: 2.238

5.  Hepatitis C virus modelled as an indirectly transmitted infection highlights the centrality of injection drug equipment in disease dynamics.

Authors:  Miles D Miller-Dickson; Victor A Meszaros; Salvador Almagro-Moreno; C Brandon Ogbunugafor
Journal:  J R Soc Interface       Date:  2019-09-04       Impact factor: 4.118

6.  Per-Contact Infectivity of Hepatitis C Virus Acquisition in Association With Receptive Needle Sharing Exposures in a Prospective Cohort of Young Adult People who Inject Drugs in San Francisco, California.

Authors:  Yuridia Leyva; Kimberly Page; Stephen Shiboski; Judith A Hahn; Jennifer Evans; Erik Erhardt
Journal:  Open Forum Infect Dis       Date:  2020-03-16       Impact factor: 3.835

7.  A model of bi-mode transmission dynamics of hepatitis C with optimal control.

Authors:  Mudassar Imran; Hassan Rafique; Adnan Khan; Tufail Malik
Journal:  Theory Biosci       Date:  2013-12-30       Impact factor: 1.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.